Foresta’s plans to build a biofuels and pine chemicals plant in Kawerau appear to be on track for now after raising more ...

Pursuant to the transaction with Telix, ImaginAb has retained its lead imaging candidate, CD8 ImmunoPET, which is currently in Phase 2 clinical trials and has been licensed by numerous pharmaceutical ...

Investors seem prepared to ignore the risks. But with uncertainty high and earnings season on the doorstep, it’s a good ...

Book messages went out on Friday afternoon saying the joint lead managers had received firm cornerstone bids and indications ...

According to a report by the Australian Bureau of Statistics (ABS) published on December 4, 2024, the Australian economy grew ...

Meta Platforms and most other US stocks are rising following a rush of profit reports from some of the country’s most ...

Property giant Lendlease will sell its interest in infrastructure investor Capella Capital to a diversified Japanese trading ...

Of course, there are plenty of index funds on the ASX that cover other markets. There's a Japanese index fund, for example, ...

Looking for a high-yield ASX dividend stock to buy today? This Vanguard income-focused ETF offers a trailing yield well north ...

The latest announcement is out from National Australia Bank Limited ( ($AU:NAB) ). National Australia Bank Limited has ...

AEMD Aethlon Medical (NASDAQ:AEMD) announced that the first patient in its Australian safety, feasibility and dose-finding ...

We do not offer financial advice, advisory or brokerage services, nor do we recommend or advise individuals or to buy or sell particular stocks or securities. Performance information may have ...